Reforming L forms: they need part of a wall after all?

One of the joys of science is seeing old problems solved. Just as satisfying is the pleasure of seeing long-unanswered questions revitalized by the application of new technologies or simply by someone reinvestigating the problem with fresh eyes. In this issue, Joseleau-Petit et al. (5) provide us the opportunity to share this second kind of enjoyment by resurrecting the rather moribund subject of Escherichia coli L forms along with the question of how bacteria survive and flourish after losing their sturdy peptidoglycan cell wall. These authors describe a new technique for converting, at will and with ease, any strain of E. coli into an L-form-like variant, and they characterize some of the physiological requirements for creating and maintaining this unusual form. The major surprise is that these cells cannot survive without a remnant of peptidoglycan, which may be required for proper cell division. L-form bacteria have a long history, beginning (as the authors note in a nice introductory retrospective) with the work of Emmy Klieneberger in 1935, who named the cells in honor of the Lister Institute of London. Several reviews summarize this early work (3, 7, 12), and a more recent article updates the historical literature on L forms, the semantic concerns about how to refer to these variants, the generation and study of several such organisms, and the pathogenic implications of this kind of life (4). Briefly, L forms are bacteria that once possessed cell walls but which have acquired the ability to grow without this rigid exoskeleton. The loss may be permanent (stable L forms) or temporary, so that some may regain their wall and grow normally (unstable L forms). Until now, the overwhelming impression has been that such cells make no peptidoglycan or, at the very least, that they need not do so. The findings of Joseleau-Petit et al. demand that this view be reevaluated for gram-negative L forms. One problem with the accepted view is that the transition from bacterium to L form should be commonplace, requiring only that the cell be in an isotonic environment and that peptidoglycan synthesis be inactivated. However, great effort is often required to generate and maintain E. coli L forms (6), including incubating the cells in complex media in the presence of high concentrations of penicillin, growing them as embedded colonies in a specific percentage of agar, and passaging them multiple times for several years. Why is it so hard to generate L forms and why can they not be created in liquid media? Joseleau-Petit et al. (5) can now explain why this has been so difficult. First of all, they introduce a procedure to generate “L-form-like” cells from any E. coli lineage. The conversion technique is straightforward, consisting of a single overnight incubation in a rich hypertonic medium in the presence of the -lactam cefsulodin. This antibiotic inhibits the transpeptidase activity of the major peptidoglycan-synthesizing enzymes, penicillin-binding proteins (PBPs) 1a and 1b (2, 8). In hypertonic media, the cells become spherical, osmosensitive, and heterogeneous in size, traits associated with L forms. Unlike their historical forbears, however, these survivors form colonies on an agar surface and propagate in liquid media. Why does this undemanding protocol succeed? The answer is that the procedure finally achieves a proper balance between the set of reactions to be inhibited versus those that must be retained. Figure 1 summarizes the basic findings. PBPs 1a and 1b are bifunctional enzymes, having a transglycosylase domain that polymerizes glycan chains and a transpeptidase domain that incorporates these polymers into the existing bacterial sacculus by cross-linking their peptide side chains. If the transpeptidases of PBPs 1a and 1b are inactivated by cefsulodin (Fig. 1B), then L-form-like cells arise. The same is true for cells lacking PBP 1a (Fig. 1C), but mutants missing PBP 1b die when exposed to cefsulodin (Fig. 1D). Thus, to create L-formlike cells the cross-linking abilities of these PBPs must be inactivated and the transglycosylase activity of PBP 1b must remain intact. This strongly implies that a peptidoglycan polymer is required for L-form survival (see below). The reason previous procedures were not as successful is because they included high concentrations of a -lactam, usually penicillin, that inhibited the transpeptidase activities of numerous PBPs. But some of these other PBPs are essential for L-form survival. Like PBPs 1a and 1b, PBPs 2 and 3 have two domains, a transpeptidase and one domain of ill-defined function. Inhibiting the transpeptidase of either PBP 2 (Fig. 1E) or PBP 3 (Fig. 1F) is lethal for L-form-like cells. This suggests not only that L-form survival may require a glycan polymer but that this polymer may have to be cross-linked by these secondary PBPs. Earlier protocols ran afoul of this requirement because they inhibited all transpeptidation. To prove conclusively that peptidoglycan synthesis was required for the survival of L forms, Joseleau-Petit et al. removed the supply of peptidoglycan precursors. Inhibiting any of three different cytosolic steps in peptidoglycan synthesis destroyed L-form growth, supporting the contention that the complete loss of peptidoglycan is not tolerated. A corroborat* Corresponding author. Mailing address: Department of Microbiology and Immunology, University of North Dakota School of Medicine, Grand Forks, ND 58202. Phone: (701) 777-2624. Fax: (701) 777-2054. E-mail: [email protected]. Published ahead of print on 20 July 2007.